Drugs that contain Vasopressin
1. Vasostrict patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10010575 | PAR STERILE PRODUCTS | Vasopressin formulations for use in treatment of hypotension |
Jan, 2035
(10 years from now) | |
| US9375478 | PAR STERILE PRODUCTS | Vasopressin formulations for use in treatment of hypotension |
Jan, 2035
(10 years from now) | |
| US9687526 | PAR STERILE PRODUCTS | Vasopressin formulations for use in treatment of hypotension |
Jan, 2035
(10 years from now) | |
| US9974827 | PAR STERILE PRODUCTS | Vasopressin formulations for use in treatment of hypotension |
Jan, 2035
(10 years from now) | |
| US9968649 | PAR STERILE PRODUCTS | Vasopressin formulations for use in treatment of hypotension |
Jan, 2035
(10 years from now) | |
| US9962422 | PAR STERILE PRODUCTS | Vasopressin formulations for use in treatment of hypotension |
Jan, 2035
(10 years from now) | |
| US9925234 | PAR STERILE PRODUCTS | Vasopressin formulations for use in treatment of hypotension |
Jan, 2035
(10 years from now) | |
| US9925233 | PAR STERILE PRODUCTS | Vasopressin formulations for use in treatment of hypotension |
Jan, 2035
(10 years from now) | |
| US9937223 | PAR STERILE PRODUCTS | Vasopressin formulations for use in treatment of hypotension |
Jan, 2035
(10 years from now) | |
| US9750785 | PAR STERILE PRODUCTS | Vasopressin formulations for use in treatment of hypotension |
Jan, 2035
(10 years from now) | |
| US9919026 | PAR STERILE PRODUCTS | Vasopressin formulations for use in treatment of hypotension |
Jan, 2035
(10 years from now) | |
| US9981006 | PAR STERILE PRODUCTS | Vasopressin formulations for use in treatment of hypotension |
Jan, 2035
(10 years from now) | |
| US9744239 | PAR STERILE PRODUCTS | Vasopressin formulations for use in treatment of hypotension |
Jan, 2035
(10 years from now) | |
| US9744209 | PAR STERILE PRODUCTS | Vasopressin formulations for use in treatment of hypotension |
Jan, 2035
(10 years from now) | |
Market Authorisation Date: 21 April, 2021
Treatment: To increase blood pressure in adults with vasodilatory shock (e.g., post-cardiotomy or sepsis) who remain hypotensive despite fluids and catecholamines
Dosage: SOLUTION;INTRAVENOUS
How can I launch a generic of VASOSTRICT before it's drug patent expiration?
More Information on Dosage
VASOSTRICT family patents
